ah.novartis.comTiamutin home page

Tiamutin safety

No human use

Tiamutin is not used in human medicine so there is no fear of cross-resistance with human antibiotics unlike the fluoroquinolones, macrolides, lincomycin or tetracyclines.

Negligible cross resistance

Tiamutin is an antibiotic of the pleuromutilin family and is not related to other antibiotics, such as the macrolides (tylosin, kitasamycin, erythromycin, josamycin and spiramycin), or the tetracyclines and there is no cross resistance between the families. Due to its lack of cross resistance Tiamutin has been shown to be active against tylosin-resistant strains [?], [?] from Germany and Middle East (see table below).
 

 

Tiamutin® (tiamulin) sensitivity to tylosin–resistant strains of M. gallisepticum
  MIC (µg/ml)
  Tylosin Tiamutin
German strains (7) 0.6 - 10.0 0.05 - 0.1
Middle East strains (11) 0.5 - 10.0 0.025 0.25

Well tolerated

Toxicity studies have shown Tiamutin is well tolerated in chickens. The LD5 (where 5% mortality occurs) for chickens is 1090 mg/kg bodyweight (44 times preventive dose) and for turkeys 840 mg/kg (28 times preventive dose). It is well distributed throughout body tissues and is metabolised and excreted primarily via the liver and kidneys.
Back to the top
Product Information

Home | Contact | Help | Legal Disclaimer | Privacy Policy
© 2007 Novartis Animal Health Inc.
Please note that not all products listed within this site may be available in all countries.
Also, prescribing information and indications for products may differ from country to country, so please
consult your local veterinarian for local prescribing and any other information you may be interested in.